BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19237332)

  • 1. Morphological and functional evaluation of visual disturbances in a bilateral hand allograft recipient.
    Landin L; Cavadas PC; Nthumba P; Muñoz G; Gallego R; Belloch V; Avila C; Loro M; Ibañez J; Roger I; Linares-Martinez N
    J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):700-4. PubMed ID: 19237332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyomavirus nephropathy after renal transplantation: a single centre experience.
    Kim HC; Hwang EA; Han SY; Park SB; Park KK
    Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant.
    Breidenbach WC; Gonzales NR; Kaufman CL; Klapheke M; Tobin GR; Gorantla VS
    J Hand Surg Am; 2008 Sep; 33(7):1039-47. PubMed ID: 18762094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft mucormycosis in a renal allograft recipient.
    Ahmad M
    J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Innsbruck hand transplant program: update at 8 years after the first transplant.
    Brandacher G; Ninkovic M; Piza-Katzer H; Gabl M; Hussl H; Rieger M; Schocke M; Egger K; Loescher W; Zelger B; Ninkovic M; Bonatti H; Boesmueller C; Mark W; Margreiter R; Schneeberger S
    Transplant Proc; 2009 Mar; 41(2):491-4. PubMed ID: 19328910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Handtransplantation and Composite Tissue Allotransplantation (CTA)].
    Gabl M; Rennekampff O
    Handchir Mikrochir Plast Chir; 2009 Aug; 41(4):203-4. PubMed ID: 19688650
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hand transplantation in the United States: experience with 3 patients.
    Ravindra KV; Buell JF; Kaufman CL; Blair B; Marvin M; Nagubandi R; Breidenbach WC
    Surgery; 2008 Oct; 144(4):638-43; discussion 643-4. PubMed ID: 18847649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serous chorioretinopathy after solid organ transplantation.
    Fawzi AA; Holland GN; Kreiger AE; Heckenlively JR; Arroyo JG; Cunningham ET
    Ophthalmology; 2006 May; 113(5):805-13.e5. PubMed ID: 16650676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Examination strategies in simulation and functional vision disorders].
    Trauzettel-Klosinski S
    Klin Monbl Augenheilkd; 1997 Aug; 211(2):73-83. PubMed ID: 9379643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional vision loss: a diagnosis of exclusion.
    Villegas RB; Ilsen PF
    Optometry; 2007 Oct; 78(10):523-33. PubMed ID: 17904493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New immunosuppressive drugs for prevention and treatment of rejection in renal transplant.
    Segoloni GP; Quaglia M
    J Nephrol; 2006; 19(5):578-86. PubMed ID: 17136684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.